Company signs a worldwide licensing agreement with Pherin Pharmaceuticals for the development and commercialization of a Phase 3-ready CNS drug candidate for as-needed treatment of social anxiety disorder Untreated social anxiety disorder has a significant impact on a person’s overall quality of life Clinical studies support the potential of PH94B to be a superior treatment […]

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales […]

A partnership with Sputnik Bank in Russia will enable the provision of third party bank processing services to local banks Regulatory approval and completion of the agreement are expected in the final quarter of 2018 Net Element is the only Nasdaq-listed U.S. company that stands to benefit from the Russian electronic payment expansion Global technology […]

The U.S. Drug Enforcement Administration (DEA) ruling enables physicians to prescribe Epidiolex, a non-synthetic cannabis-derived medicine from United Kingdom-grown cannabis Cannabis entrepreneurs applaud the decision, even though it only applies to that specific drug; DEA decision requires approval of medications by the U.S. Food & Drug Administration (FDA) Several other CBD medications are in the […]

The three online platforms provide a strategic step forward in advancing the company’s business model by creating tools to introduce the existing portfolio brands into vertical markets Again the company is setting itself apart by further demonstrating a unique business approach toward advancing operations and creating value in the sector The acquisition portfolio has the […]

SeeThruEquity recommends a share price of $0.30 Bill would make hemp an ordinary agricultural product and no longer a controlled substance Hemp-derived cannabidiol market worth $591 million, expected to hit $22 billion in under five years With the U.S. Congress on the verge of making hemp an ordinary agricultural crop instead of a controlled substance, […]

Technology partnership signed with Integral Genomics Inc. (dba Lighthouse Genomics Inc.) to support BLOCKStrain’s registry of genetic profiles of cannabis strains Valuable intellectual property rights of cannabis cultivators under attack from unscrupulous illegal growers, gray market Recent reschedule of first FDA-approved drug derived from cannabis paves the way for sales, underscores necessity of BLOCKStrain’s “Single […]

Iron Creek estimates call for 45 million pounds (20,411 tonnes) of cobalt Drilling underway for expanded resource estimate that’s expected in 2019 Board strengthened with appointment of CEO of electric vehicle innovator Cobalt resource estimates in North America just got a boost, after First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) released the results […]

Average daily GreenBox transaction volume projected to reach $1 million by 4Q2018 Recently announced completion of parent company takeover, ensuring that all assets are now transferred onto GRBX’s books as planned Acquisition of Sky Mids Technologies includes Sky’s book of transactional business capable of processing greater than $1 billion annually Global point-of-sale terminals market expected […]

Completion of full audit for fiscal year ended March 31, 2018 Close of three-year audit required to become fully reporting company with SEC Plans afoot to uplist to a higher OTC Markets tier Cannabis Strategic Ventures, Inc. (OTC: NUGS) wants to be an open book. The company has announced the completion of a full audit […]